UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

How to Position Pasireotide LAR Treatment in Acromegaly

The journal of clinical endocrinology and metabolism, 2019-06, Vol.104 (6), p.1978-1988

2019

Volltextzugriff (PDF)

Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin

Endocrine reviews, 2004-06, Vol.25 (3), p.426-457

2004

Volltextzugriff (PDF)

The acylated (AG) to unacylated (UAG) ghrelin ratio in esterase inhibitor-treated blood is higher than previously described

Clinical endocrinology (Oxford), 2015-01, Vol.82 (1), p.142-146

2015

Volltextzugriff (PDF)

Effect of long-term GH replacement therapy on cardiovascular outcomes in GH-deficient patients previously treated for acromegaly: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults

European journal of endocrinology, 2014-12, Vol.171 (6), p.717

2014

Volltextzugriff (PDF)

Ghrelin: a new treatment for non-alcoholic fatty liver disease?

Endocrine, 2013-04, Vol.43 (2), p.247-248

2013

Volltextzugriff (PDF)

Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin

European journal of endocrinology, 2012-11, Vol.167 (5), p.601

2012

Volltextzugriff (PDF)

Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

Journal of the Endocrine Society, 2021-03, Vol.5 (3), p.bvaa205

2021

Volltextzugriff (PDF)

Dynamics of the acute effects of octreotide, bromocriptine and both drugs in combination on growth hormone secretion in acromegaly

Acta endocrinologica (Copenhagen), 1991-12, Vol.125 (6), p.637

1991

Volltextzugriff (PDF)

Very long-term sequelae of craniopharyngioma

European journal of endocrinology, 2017-06, Vol.176 (6), p.755

2017

Volltextzugriff (PDF)

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly

European journal of endocrinology, 2020-06, Vol.182 (6), p.595

2020

Volltextzugriff (PDF)

Soluble Klotho: a possible predictor of quality of life in acromegaly patients

Endocrine, 2020-07, Vol.69 (1), p.165-174

2020

Volltextzugriff (PDF)

Unacylated Ghrelin Rapidly Modulates Lipogenic and Insulin Signaling Pathway Gene Expression in Metabolically Active Tissues of GHSR Deleted Mice

PloS one, 2010-07, Vol.5 (7), p.e11749-e11749

2010

Volltextzugriff (PDF)

Direct activating effects of adrenocorticotropic hormone (ACTH) on brown adipose tissue are attenuated by corticosterone

The FASEB journal, 2014-11, Vol.28 (11), p.4857-4867

2014

Volltextzugriff (PDF)

The Endocrinology of Aging

Science (American Association for the Advancement of Science), 1997-10, Vol.278 (5337), p.419-424

1997

Volltextzugriff (PDF)

Ghrelin Stimulates, Whereas Des-Octanoyl Ghrelin Inhibits, Glucose Output by Primary Hepatocytes

The journal of clinical endocrinology and metabolism, 2005-02, Vol.90 (2), p.1055-1060

2005

Volltextzugriff (PDF)

Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells

American journal of physiology: endocrinology and metabolism, 2003-08, Vol.285 (2), p.E344-E353

2003

Volltextzugriff (PDF)

A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients

The journal of clinical endocrinology and metabolism, 2004-02, Vol.89 (2), p.638-645

2004

Volltextzugriff (PDF)

Pegvisomant Treatment in Acromegaly

Neuroendocrinology, 2016-01, Vol.103 (1), p.59-65

2016

Volltextzugriff (PDF)

Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans

The journal of clinical endocrinology and metabolism, 2001-10, Vol.86 (10), p.5083-5086

2001

Volltextzugriff (PDF)

Des‐acyl ghrelin analogs prevent high‐fat‐diet‐induced dysregulation of glucose homeostasis

The FASEB journal, 2013-04, Vol.27 (4), p.1690-1700

2013

Volltextzugriff (PDF)

The Endocrine Response to Ghrelin as a Function of Gender in Humans in Young and Elderly Subjects

The journal of clinical endocrinology and metabolism, 2003-04, Vol.88 (4), p.1537-1542

2003

Volltextzugriff (PDF)

Ghrelin Secretion Is Inhibited by Either Somatostatin or Cortistatin in Humans

The journal of clinical endocrinology and metabolism, 2002-10, Vol.87 (10), p.4829-4832

2002

Volltextzugriff (PDF)

Bridging the gap: metabolic and endocrine care of patients during transition

Endocrine Connections, 2016-11, Vol.5 (6), p.R44-R54

2016

Volltextzugriff (PDF)

Unacylated ghrelin acts as a potent insulin secretagogue in glucose-stimulated conditions

American journal of physiology: endocrinology and metabolism, 2007-09, Vol.293 (3), p.E697-E704

2007

Volltextzugriff (PDF)

Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetes

European journal of endocrinology, 2009-10, Vol.161 (4), p.567

2009

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(26)
Endocrinology & Metabolism
(25)
Humans
(23)
Male
(18)
Biological And Medical Sciences
(15)
Adult
(13)
Endocrinology
(13)
Female
(12)
Animals
(11)
Endocrinology, Diabetes And Metabolism
(10)
Fundamental And Applied Biological Sciences. Psychology
(10)
Ghrelin
(10)
Medical Sciences
(10)
Vertebrates: Endocrinology
(9)
Endocrinopathies
(7)
Insulin - Blood
(7)
Middle Aged
(7)
Aged
(6)
Blood Glucose - Analysis
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

How to Position Pasireotide LAR Treatment in Acromegaly

Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin

The acylated (AG) to unacylated (UAG) ghrelin ratio in esterase inhibitor-treated blood is higher than previously described

Effect of long-term GH replacement therapy on cardiovascular outcomes in GH-deficient patients previously treated for acromegaly: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults

Ghrelin: a new treatment for non-alcoholic fatty liver disease?

Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin

Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

Dynamics of the acute effects of octreotide, bromocriptine and both drugs in combination on growth hormone secretion in acromegaly

Very long-term sequelae of craniopharyngioma

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly

Soluble Klotho: a possible predictor of quality of life in acromegaly patients

Unacylated Ghrelin Rapidly Modulates Lipogenic and Insulin Signaling Pathway Gene Expression in Metabolically Active Tissues of GHSR Deleted Mice

Direct activating effects of adrenocorticotropic hormone (ACTH) on brown adipose tissue are attenuated by corticosterone

The Endocrinology of Aging

Ghrelin Stimulates, Whereas Des-Octanoyl Ghrelin Inhibits, Glucose Output by Primary Hepatocytes

Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells

A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients

Pegvisomant Treatment in Acromegaly

Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans

Des‐acyl ghrelin analogs prevent high‐fat‐diet‐induced dysregulation of glucose homeostasis

The Endocrine Response to Ghrelin as a Function of Gender in Humans in Young and Elderly Subjects

Ghrelin Secretion Is Inhibited by Either Somatostatin or Cortistatin in Humans

Bridging the gap: metabolic and endocrine care of patients during transition

Unacylated ghrelin acts as a potent insulin secretagogue in glucose-stimulated conditions

Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetes

Aktive Filter

Suchergebnisse filtern